Michael J Pencina

Michael J Pencina's AcademicInfluence.com Rankings

Michael J Pencina

Mathematics

#5098

World Rank

#7207

Historical Rank

Statistics

#312

World Rank

#374

Historical Rank

Measure Theory

#591

World Rank

#823

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Michael J Pencina's Degrees

PhD Biostatistics Stanford University
Masters Statistics Stanford University

Why Is Michael J Pencina Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael J Pencina's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study (2008) (5834)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (2008) (5711)
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures (2010) (3297)
Vitamin D Deficiency and Risk of Cardiovascular Disease (2008) (2511)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers (2011) (2069)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. (2015) (1907)
Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study (2010) (1835)
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation (2004) (1320)
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. (2012) (997)
One-year cardiovascular event rates in outpatients with atherothrombosis. (2007) (987)
On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data (2011) (937)
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study (2009) (932)
Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study (2009) (797)
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial (2019) (749)
Carotid-wall intima-media thickness and cardiovascular events. (2011) (710)
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (2014) (698)
Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve (2011) (683)
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. (2007) (621)
Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005 (2009) (563)
Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium (2013) (561)
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study (2007) (556)
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. (2009) (553)
Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review (2017) (545)
Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. (2012) (517)
Application of new cholesterol guidelines to a population-based sample. (2014) (486)
Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction (2008) (443)
A calibration hierarchy for risk models was defined: from utopia to empirical data. (2016) (411)
Interpreting incremental value of markers added to risk prediction models. (2012) (408)
Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study (2006) (386)
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. (2007) (382)
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. (2011) (365)
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation (2015) (343)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. (2015) (332)
Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. (2010) (324)
Statistical methods for assessment of added usefulness of new biomarkers (2010) (307)
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) (2017) (292)
Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study (2009) (280)
Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease (2015) (279)
Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. (2008) (277)
Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. (2008) (276)
Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. (2011) (270)
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study (2008) (267)
A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study (2008) (267)
Evaluating Discrimination of Risk Prediction Models: The C Statistic. (2015) (263)
Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community (2010) (262)
Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. (2005) (257)
C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. (2005) (255)
Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models (2012) (254)
Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. (2013) (242)
Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. (2014) (237)
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. (2012) (228)
Net Reclassification Improvement: Computation, Interpretation, and Controversies (2014) (228)
Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. (2010) (224)
Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men (2006) (222)
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
A Genetic Risk Score Is Associated With Incident Cardiovascular Disease and Coronary Artery Calcium: The Framingham Heart Study (2012) (216)
Cardiovascular Disease Risk Assessment: Insights from Framingham. (2013) (216)
Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study (2007) (206)
Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. (2013) (203)
Coronary Computed Tomographic Angiography and Risk of All-Cause Mortality and Nonfatal Myocardial Infarction in Subjects Without Chest Pain Syndrome From the CONFIRM Registry (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) (2012) (203)
Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study (2008) (201)
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial. (2016) (195)
Misuse of DeLong test to compare AUCs for nested models (2012) (194)
Clinical implications of chronic heart failure phenotypes defined by cluster analysis. (2014) (192)
Increasing trends in incidence of overweight and obesity over 5 decades. (2007) (187)
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. (2019) (182)
An international model to predict recurrent cardiovascular disease. (2012) (181)
Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors: The Framingham Offspring Study (2007) (179)
Assessing the incremental value of diagnostic and prognostic markers: a review and illustration (2012) (177)
Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short- and Long-Term Change in the Framingham Offspring Study (2009) (173)
Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms (2010) (171)
Association of parental heart failure with risk of heart failure in offspring. (2006) (169)
Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial. (2020) (168)
Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry. (2011) (165)
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent (2010) (162)
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. (2009) (161)
Choice of time scale and its effect on significance of predictors in longitudinal studies (2007) (161)
Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation (2017) (157)
Estimated Risks for Developing Obesity in the Framingham Heart Study (2005) (157)
Common Carotid Artery Intima-Media Thickness Progression as a Predictor of Stroke in Multi-Ethnic Study of Atherosclerosis (2011) (155)
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S] (2009) (152)
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. (2010) (151)
Cardiovascular Risk Factors Predictive for Survival and Morbidity‐Free Survival in the Oldest‐Old Framingham Heart Study Participants (2005) (144)
Application of New Cholesterol Guidelines to a Population-Based Sample (2014) (144)
B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. (2014) (141)
Validation of an atrial fibrillation risk algorithm in whites and African Americans. (2010) (134)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement (2019) (132)
Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community (2009) (131)
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. (2016) (130)
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. (2010) (129)
Embolic Protection and Platelet Inhibition During Renal Artery Stenting (2008) (129)
Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. (2012) (127)
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. (2014) (124)
Associations of Carotid Artery Intima‐Media Thickness (IMT) With Risk Factors and Prevalent Cardiovascular Disease (2010) (124)
Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. (2005) (122)
A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit* (2010) (119)
Diet quality and obesity in women: the Framingham Nutrition Studies (2009) (117)
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study) (2012) (116)
Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. (2013) (114)
Determining When to Add Nonstatin Therapy: A Quantitative Approach. (2016) (113)
Electrocardiographic QRS Duration and the Risk of Congestive Heart Failure: The Framingham Heart Study (2006) (111)
Troponin criteria for myocardial infarction after percutaneous coronary intervention. (2012) (109)
Proportion of US adults potentially affected by the 2014 hypertension guideline. (2014) (108)
Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. (2014) (105)
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C (2015) (105)
Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms (2010) (104)
Comments on ‘Integrated discrimination and net reclassification improvements—Practical advice’ (2008) (102)
Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. (2006) (100)
Longitudinal FGF23 Trajectories and Mortality in Patients with CKD. (2017) (99)
Unique dietary patterns and chronic disease risk profiles of adult men: the Framingham nutrition studies. (2005) (95)
Risk assessment for incident heart failure in individuals with atrial fibrillation (2013) (95)
Charting a roadmap for heart failure biomarker studies. (2014) (95)
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. (2013) (94)
Trends in Diabetes Incidence: The Framingham Heart Study (2014) (91)
Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome. (2012) (91)
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. (2013) (89)
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. (2009) (89)
Quantifying Importance of Major Risk Factors for Coronary Heart Disease (2018) (88)
Using Propensity Score Methods to Create Target Populations in Observational Clinical Research. (2020) (87)
Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice: Derivation and Validation of a Risk Model From the EVENT Registry (2010) (87)
Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure: The Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial. (2019) (86)
Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record. (2016) (86)
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial. (2016) (85)
Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison. (2017) (84)
BMI vs. Waist Circumference for Identifying Vascular Risk (2008) (84)
Routine Laboratory Results and Thirty Day and One-Year Mortality Risk Following Hospitalization with Acute Decompensated Heart Failure (2010) (82)
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial (2014) (81)
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. (2021) (80)
Quantifying discrimination of Framingham risk functions with different survival C statistics (2012) (80)
Sex Hormone–Binding Globulin, but Not Testosterone, Is Associated Prospectively and Independently With Incident Metabolic Syndrome in Men (2011) (79)
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
Evaluation of Markers and Risk Prediction Models (2013) (76)
Genetic Predisposition to Higher Blood Pressure Increases Coronary Artery Disease Risk (2013) (75)
Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? (2009) (74)
P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study. (2015) (74)
Neck Circumference and the Development of Cardiovascular Disease Risk Factors in the Framingham Heart Study (2012) (74)
Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. (2013) (74)
Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease (2016) (73)
Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes. (2016) (71)
Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. (2013) (69)
Dietary Quality Predicts Adult Weight Gain: Findings from the Framingham Offspring Study (2006) (69)
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk (2018) (69)
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life (2018) (68)
Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. (2012) (67)
Net reclassification index at event rate: properties and relationships (2017) (67)
A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. (2012) (67)
Use of Open Access Platforms for Clinical Trial Data. (2016) (66)
Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results From the Evaluation of Drug Eluting Stents and Ischemic Events Registry (2008) (66)
Characteristics of Framingham offspring participants with long-lived parents. (2007) (65)
Diet quality, physical activity, smoking status, and weight fluctuation are associated with weight change in women and men. (2010) (64)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration (2019) (64)
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. (2013) (63)
The Role of Physicians in the Era of Predictive Analytics. (2015) (63)
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? (2013) (63)
Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all. (2015) (62)
Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study (2015) (62)
Prognostic value of PET myocardial perfusion imaging in obese patients. (2014) (61)
Stress Cardiac Magnetic Resonance Imaging Provides Effective Cardiac Risk Reclassification in Patients With Known or Suspected Stable Coronary Artery Disease (2013) (61)
Reclassification calculations for persons with incomplete follow-up. (2010) (61)
Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular care (2020) (61)
Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events. (2012) (61)
Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the Community (2009) (59)
Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study. (2019) (59)
Temporal trends in self-reported functional limitations and physical disability among the community-dwelling elderly population: the Framingham heart study. (2008) (59)
Atrial Fibrillation Patterns and Risks of Subsequent Stroke, Heart Failure, or Death in the Community (2013) (59)
Alcoholism and judgments of affective stimuli. (2007) (58)
Prevalence, Clinical Correlates, and Prognosis of Discrete Upper Septal Thickening on Echocardiography: The Framingham Heart Study (2009) (57)
Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. (2015) (57)
Prediction Models - Development, Evaluation, and Clinical Application. (2020) (56)
Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. (2016) (56)
Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. (2016) (56)
Sex‐Specific Differences in the Predictive Value of Cholesterol Homeostasis Markers and 10‐Year Cardiovascular Disease Event Rate in Framingham Offspring Study Participants (2013) (55)
Advance care planning and health care preferences of community-dwelling elders: the Framingham Heart Study. (2008) (55)
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. (2016) (55)
Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines (2017) (55)
Admission Cell Free DNA Levels Predict 28-Day Mortality in Patients with Severe Sepsis in Intensive Care (2014) (55)
Seasonal and circadian variations of acute myocardial infarction: Findings from the Get With The Guidelines–Coronary Artery Disease (GWTG‐CAD) program (2017) (54)
On Deep Learning for Medical Image Analysis. (2018) (54)
Repeat Revascularization After Contemporary Percutaneous Coronary Intervention: An Evaluation of Staged, Target Lesion, and Other Unplanned Revascularization Procedures During the First Year (2012) (54)
Associations of Edge-Detected and Manual-Traced Common Carotid Intima-Media Thickness Measurements With Framingham Risk Factors: The Multi-Ethnic Study of Atherosclerosis (2011) (54)
Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome. (2013) (53)
Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study. (2016) (52)
How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through (2014) (52)
The PARACHUTE IV trial design and rationale: percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles. (2013) (52)
Choice of agreement indices for assessing and improving measurement reproducibility in a core laboratory setting (2016) (51)
Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort. (2016) (51)
Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling. (2016) (50)
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration (2011) (50)
Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective (2014) (50)
Prognostic Implications of Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry (2011) (49)
Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention. (2019) (49)
Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events. (2016) (47)
Clinical and Economic Outcomes of Liberal Versus Selective Drug-Eluting Stent Use: Insights From Temporal Analysis of the Multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry (2011) (47)
Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus (2017) (47)
Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care. (2015) (46)
A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies (2013) (45)
Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient‐Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2015) (44)
Relations of Insulin Sensitivity to Longitudinal Blood Pressure Tracking: Variations With Baseline Age, Body Mass Index, and Blood Pressure (2005) (44)
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. (2020) (44)
The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials. (2013) (44)
Predicted long-term cardiovascular risk among young adults in the national longitudinal study of adolescent health. (2014) (44)
Medidas del rendimiento de modelos de predicción y marcadores pronósticos: evaluación de las predicciones y clasificaciones (2011) (44)
Data monitoring committees: Promoting best practices to address emerging challenges (2017) (44)
A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study (2016) (43)
Evaluating Treatment Efficacy by Multiple End Points in Phase II Acute Heart Failure Clinical Trials: Analyzing Data Using a Global Method (2012) (43)
Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. (2015) (43)
Prevalence of diabetes and impaired fasting glucose in Poland—the NATPOL 2011 Study (2014) (43)
Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention (2012) (43)
Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment. (2011) (42)
Genotype Prediction of Adult Type 2 Diabetes From Adolescence in a Multiracial Population (2012) (42)
Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol (2016) (42)
Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics (2010) (41)
Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs. (2015) (40)
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis (2017) (40)
Egg Consumption and Risk of Total and Cause-Specific Mortality: An Individual-Based Cohort Study and Pooling Prospective Studies on Behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2019) (40)
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials (2013) (40)
A SAS ® Macro to Compute Added Predictive Ability of New Markers Predicting a Dichotomous Outcome (2010) (39)
Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data. (2015) (38)
Discrimination slope and integrated discrimination improvement – properties, relationships and impact of calibration (2017) (37)
Early-Adulthood Cardiovascular Disease Risk Factor Profiles Among Individuals With and Without Diabetes in the Framingham Heart Study (2013) (37)
[Performance measures for prediction models and markers: evaluation of predictions and classifications]. (2011) (36)
Relation of corneal arcus to cardiovascular disease (from the Framingham Heart Study data set). (2009) (36)
Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research) (2016) (35)
Medical history for prognostic risk assessment and diagnosis of stable patients with suspected coronary artery disease. (2015) (35)
Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality (2011) (34)
Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative (2017) (34)
Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients. (2014) (33)
Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: A meta‐analysis and critical examination of current methodologies (2014) (32)
A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis (2017) (32)
Critical Review of Current Approaches for Echocardiographic Reproducibility and Reliability Assessment in Clinical Research. (2016) (31)
Understanding increments in model performance metrics (2013) (31)
Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research (2019) (30)
Association of Parental Hypertension With Concentrations of Select Biomarkers in Nonhypertensive Offspring (2008) (29)
Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment. (2016) (29)
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). (2012) (29)
Hybrid comprehensive telerehabilitation in heart failure patients (TELEREH-HF): A randomized, multicenter, prospective, open-label, parallel group controlled trial-Study design and description of the intervention. (2019) (29)
Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: a systematic review and meta-analysis. (2016) (29)
Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. (2013) (29)
Application of net reclassification index to non-nested and point-based risk prediction models: a review. (2018) (28)
Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives (2014) (28)
Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk. (2019) (28)
The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering (2020) (27)
Supporting open access to clinical trial data for researchers: The Duke Clinical Research Institute-Bristol-Myers Squibb Supporting Open Access to Researchers Initiative. (2016) (27)
Assessing the incremental predictive performance of novel biomarkers over standard predictors (2014) (27)
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates. (2016) (27)
Aortic Root Diameter and Longitudinal Blood Pressure Tracking (2008) (26)
Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. (2015) (26)
Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: Results From a Propensity Score–Matched Analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry (2011) (26)
Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. (2011) (26)
An Obesity Dietary Quality Index Predicts Abdominal Obesity in Women: Potential Opportunity for New Prevention and Treatment Paradigms (2010) (26)
Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence. (2016) (25)
Taking a longer term view of cardiovascular risk: the causal exposure paradigm (2014) (25)
Predicting mortality over different time horizons: which data elements are needed? (2017) (24)
Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review. (2022) (23)
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration (2011) (22)
Familial Aggregation of Left Ventricular Geometry and Association With Parental Heart Failure: The Framingham Heart Study (2010) (22)
Risk Prediction With Electronic Health Records: The Importance of Model Validation and Clinical Context. (2016) (22)
Trends in the Association of Parental History of Obesity over 60 Years (2013) (22)
Do Not Over (P) Value Your Research Article. (2016) (22)
What to expect from net reclassification improvement with three categories (2014) (22)
University students' notebook computer use. (2009) (22)
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. (2012) (20)
Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study. (2011) (20)
Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension (2017) (20)
Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment. (2012) (20)
Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study (2008) (19)
Impact of correlation on predictive ability of biomarkers (2013) (19)
Association of Parental Obesity with Concentrations of Select Systemic Biomarkers in Non-obese Offspring : The Framingham Heart Study (2008) (19)
Trends in All-Cause and Cardiovascular Disease Mortality among Women and Men with and without Diabetes in the Framingham Heart Study, 1950-2005 (2009) (19)
Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. (2005) (19)
A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention (2018) (19)
Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. (2004) (18)
Placebo non‐response measure in sequential parallel comparison design studies (2015) (17)
Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. (2013) (17)
Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2011) (16)
Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States. (2016) (16)
Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U‐statistics (2017) (15)
Lifetime risk for developing dyslipidemia: the Framingham Offspring Study. (2007) (15)
Multivessel drug‐eluting stenting and impact of diabetes mellitus—A report from the EVENT registry (2009) (15)
A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: A modeling study. (2015) (15)
ApoB: The Power of Physiology to Transform the Prevention of Cardiovascular Disease (2019) (14)
Nonparametric estimation and inference for polytomous discrimination index (2018) (14)
Heparin Monotherapy or Bivalirudin During Percutaneous Coronary Intervention in Patients With Non–ST-Segment–Elevation Acute Coronary Syndromes or Stable Ischemic Heart Disease: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events Registry (2014) (14)
Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community (2011) (14)
Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis (2011) (14)
Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort--invited commentary. (2008) (14)
The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines (2017) (14)
Independent data monitoring committees: preparing a path for the future. (2014) (13)
Performance Measures for Prediction Models and Markers: Evaluation of Predictions and Classifications (2011) (13)
Quantifying cardiometabolic risk using modifiable non-self-reported risk factors. (2014) (13)
Thoroughly Modern Risk Prediction? (2012) (13)
The Dose-Response Relationship Between Physical Activity and Cardiometabolic Health in Adolescents. (2021) (13)
Estimating lifetime risk of developing high serum total cholesterol: adjustment for baseline prevalence and single-occasion measurements. (2006) (13)
Parental intermittent claudication as risk factor for claudication in adults. (2012) (13)
Validation of a breast cancer risk prediction model developed for Black women. (2013) (12)
Association of Parental Obesity With Concentrations of Select Systemic Biomarkers in Nonobese Offspring (2009) (12)
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community (2009) (12)
Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated (2018) (12)
Performance of a method for identifying the unique dietary patterns of adult women and men: the Framingham nutrition studies. (2008) (12)
Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. (2010) (12)
Long‐term efficacy and safety of zotarolimus‐eluting stent in patients with diabetes mellitus: Pooled 5‐year results from the ENDEAVOR III and IV trials (2013) (12)
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. (2009) (12)
Limitations in the conventional assessment of the incremental value of predictors of cardiovascular risk. (2015) (11)
Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance. (2012) (11)
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. (2019) (11)
Incremental Benefits of Machine Learning-When Do We Need a Better Mousetrap? (2021) (11)
Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. (2014) (11)
On the quantitative assessment of predictive biomarkers. (2015) (10)
Incremental value of rare genetic variants for the prediction of multifactorial diseases (2013) (10)
RE: net risk reclassification P Values: valid or misleading? (2014) (10)
Predictive models in heart failure: who cares? (2013) (10)
An outcome model approach to transporting a randomized controlled trial results to a target population (2018) (9)
Assessment of Administrative Data to Identify Acute Myocardial Infarction in Electronic Health Records. (2016) (9)
Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. (2013) (9)
Calibration and Uncertainty in Neural Time-to-Event Modeling (2020) (9)
Enabling counterfactual survival analysis with balanced representations (2021) (9)
The Enigma of Glucose and Lipid Metabolism. (2016) (9)
High‐sensitivity C‐reactive protein elevation in patients with prior myocardial infarction in the United States (2018) (9)
Statistical methods for building better biomarkers of chronic kidney disease (2019) (9)
Quality of life in heart failure patients undergoing hybrid comprehensive telerehabilitation versus usual care – results of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial (2020) (9)
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. (2019) (8)
Sensitivity and Specificity Can Change in Opposite Directions When New Predictive Markers Are Added to Risk Models (2014) (8)
Response to Letters Regarding Article, “Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study” (2010) (8)
A confidence ellipse for the Net Reclassification Improvement (2015) (8)
Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease (2015) (8)
Inference for reclassification statistics under nested and non-nested models for biomarker evaluation (2015) (8)
The Knowledge and Awareness of Hypertension Among Patients With Hypertension in Central Poland (2014) (8)
Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement. (2017) (8)
The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression (2013) (8)
Deriving Real-World Insights From Real-World Data: Biostatistics to the Rescue (2018) (7)
Investigating dysfunctional-hdl in selected groups of patients at high risk of cardiovascular events (DYS-HDL study) - Protocol and organization (2014) (7)
Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles (2017) (7)
Adherence to Adding Inhaled Corticosteroids to Rescue Therapy in a Pragmatic Trial with Adults with Asthma- a Pilot Study. (2020) (7)
Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community (2011) (7)
Abstract 1466: Obesity is Independently Associated With Long-term Risk of Cardiovascular Mortality and Underweight With Risk of Non-cardiovascular Mortality in Framingham Offspring Cohort (2009) (7)
Incremental prognostic value of renal function for stroke prediction in atrial fibrillation. (2019) (7)
Caution is needed in the interpretation of added value of biomarkers analyzed in matched case control studies. (2012) (7)
Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). (2011) (6)
Measuring carotid artery intima-media thickness: simplicity versus complexity? (2012) (6)
Comparison of Operating Characteristics of Commonly Used Sample Size Re-Estimation Procedures in a Two-Stage Design (2013) (6)
Remote Monitoring of Cardiac Implantable Electronic Devices in Patients Undergoing Hybrid Comprehensive Telerehabilitation in Comparison to the Usual Care. Subanalysis from Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomised Clinical Trial (2020) (6)
Cross-sectional relations of lipid concentrations to left ventricular structural attributes. (2010) (6)
Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events. (2015) (6)
Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). (2020) (6)
Placebo Response as a Latent Characteristic: Application to Analysis of Sequential Parallel Comparison Design Studies (2018) (5)
Pencina et al. respond to "The incremental value of new markers" and "Clinically relevant measures? A note of caution". (2012) (5)
The Dose-Response Relationship Between Physical Activity and Cardiometabolic Health in Young Adults. (2020) (5)
A framework for the oversight and local deployment of safe and high-quality prediction models (2022) (4)
Multi-category diagnostic accuracy based on logistic regression (2017) (4)
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration (2011) (4)
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. (2011) (4)
Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models (2019) (4)
Response to ‘Net reclassification improvement and decision theory’ by Vickers et al. (2009) (4)
Comparison of Academic and Nonacademic Sites in Multi-Center Clinical Trials (2012) (4)
Influence of exercise training on T-wave alternans assessed during exercise test in heart failure patients. (2014) (4)
FIRST DosingClopidogrelBasedon CYP 2 C 19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease (2011) (4)
Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort. (2015) (4)
Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults (2022) (4)
Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). (2020) (4)
Sample Size Calculation for Poisson Endpoint Using the Exact Distribution of Difference Between Two Poisson Random Variables (2011) (3)
Authors' response to comments (2017) (3)
An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial (2021) (3)
Abstract 1254: Development of a Risk Score for Incident Atrial Fibrillation in the Community; the Framingham Heart Study (2008) (3)
Risk Assessment to Predict Arterial and Venous Events in Patients Undergoing Percutaneous Coronary Intervention (2014) (3)
Abstract 18053: Prognostic Value of Anatomic versus Functional Diagnostic Testing in Symptomatic Patients With Suspected CAD: The PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) (2015) (3)
Algorithms for assessing cardiovascular risk in women. (2007) (3)
Correction to How to interpret a small increase in AUC with an additional risk prediction marker: Decision analysis comes through [Statist. Med. (2015) 33, 22, 3946-3959] DOI: 10.1002/sim.6195 (2014) (3)
Effects of hybrid comprehensive telerehabilitation on cardiopulmonary capacity in heart failure patients depending on diabetes mellitus: subanalysis of the TELEREH-HF randomized clinical trial (2021) (3)
[Discriminative ability, reclassification and net benefit: the predictive value of biomarkers]. (2012) (3)
Quality of life in heart failure patients undergoing hybrid comprehensive telerehabilitation versus usual care results of TELEREH-HF randomized clinical trial (2020) (3)
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents. (2010) (3)
Prevention of cardiovascular disease: time for a course correction. (2020) (3)
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. (2011) (3)
P-wave Indices and Atrial Fibrillation : Cross-Cohort Assessments from the Framingham Heart Study and Atherosclerosis Risk in Communities Study (2014) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups. (2023) (2)
Abstract No. 146: Prevalence of Low Ankle-Brachial Index, Elevated Plasma Fibrinogen and CRP Among Those Otherwise at Low-Intermediate Cardiovascular Events' Risk: Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004 (2009) (2)
RECURRENT CARDIOVASCULAR EVENT RATES IN A CONTEMPORARY COHORT OF 829,498 ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (2017) (2)
Assessment of ECG during hybrid comprehensive telerehabilitation in heart failure patients—Subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) randomized clinical trial (2021) (2)
Dietary patterns of women and men, apoe genotypes, and prevalence of the metabolic syndrome. The Framingham nutrition studies (2004) (2)
Survival Analysis meets Counterfactual Inference (2020) (2)
RISK SCORES AND BIOMARKERS FOR THE PREDICTION OF 1-YEAR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2015) (2)
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA ® ): A randomized, double-blind, placebo-control (2018) (2)
Developing Implementable Risk Prediction Models with Electronic Health Records Data (2019) (2)
Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey. (2017) (2)
Microsimulation model to predict incremental value of biomarkers added to prognostic models (2018) (2)
Evaluating Treatment Efficacy by Multiple Endpoints in Phase II Acute Heart Failure Clinical Trials: Analyzing Data Using a Global Method (2012) (2)
Authors' reply (2012) (1)
Cardiovascular Disease Risk Factor Profiles Among Individuals With and Without Diabetes in the Framingham Heart Study (2013) (1)
A calibration hierarchy for risk models: strong calibration occurs only in utopia (2015) (1)
Antiarrhythmic effect of 9-week hybrid cardiac telerehabilitation - subanalysis of the TELEREHabilitation in Heart Failure patients - TELEREH-HF randomized clinical trial (2021) (1)
Open Access Platforms for Sharing Clinical Trial Data--Reply. (2016) (1)
CONFIRM Registry (Coronary CT Angiography Evaluation for Clinical Outcomes: An Nonfatal Myocardial Infarction in Subjects Without Chest Pain Syndrome From the Coronary Computed Tomographic Angiography and Risk of All-Cause Mortality and (2013) (1)
Single‐number summary and decision analytic measures can happily coexist (2019) (1)
Statins at Dialysis Transition-Supportive but Not Sufficient. (2018) (1)
Abstract 1012: Added Value of the Common and Internal Carotid Intima-media Thickness (IMT) for the Prediction of Cardiovascular Events: The Framingham Offspring Study (2009) (1)
Segment-specific association between plasma homocysteine and carotid artery intima-media thickness in the Framingham Heart Study (2012) (1)
Testing Clinical Prediction Models. (2020) (1)
Patients affected by changes to hypertension guideline--reply. (2014) (1)
COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (1)
Absolute vs Additive Net Reclassification Index. (2018) (1)
A Systematic Review of Using Electronic Heath Records to Predict Clinical Events: Assessment of Opportunities and Challenges (2016) (1)
An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study. (2022) (1)
RELATIONSHIP OF NON-OBSTRUCTIVE CORONARY ARTERY DISEASE TO MORTALITY: RESULTS FROM 18,037 PATIENTS WITH <50% STENOSIS IN THE CONFIRM REGISTRY (CORONARY CT ANGIOGRAPHY EVALUATION FOR CLINICAL OUTCOMES: AN INTERNATIONAL MULTICENTER REGISTRY) (2011) (1)
Extrapolating Survival From Randomized Clinical Trial Data-Possibilities and Caution. (2021) (1)
Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country. (2019) (1)
Scientific, societal, and economic consequences of releasing interim data from clinical trials (2017) (1)
Time to Revisit Using 10-Year Risk to Guide Statin Therapy. (2022) (1)
Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease". (2015) (1)
PATIENTS’ PERCEIVED VERSUS PREDICTED CARDIOVASCULAR DISEASE RISK: CHALLENGES FOR SHARED DECISION-MAKING IN CHOLESTEROL MANAGEMENT (2016) (1)
Estimation of Risk for Initial Atherosclerotic Cardiovascular Disease Events: Taking Stock and Moving Forward. (2016) (1)
Competing Risks, Treatment Switching, and Informative Censoring. (2021) (1)
Clinical reasoning and prevention of cardiovascular disease. (2021) (1)
Abstract 17557: Genetic Variants Primarily Associated eith Type 2 Diabetes Also Affect Coronary Artery Disease Risk (2012) (1)
Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance (2014) (1)
P291Predicting recurrent CVD events among adults with stable CVD: a new risk model based on pooled NIH cohorts (2018) (1)
Antiarrhythmic effect of 9-week hybrid comprehensive telerehabilitation and its influence on cardiovascular mortality in long-term follow-up – subanalysis of the TELEREHabilitation in Heart Failure Patients randomized clinical trial (2021) (1)
Abstract 13709: Incident Congestive Heart Failure and Common Carotid Artery Diameter: The Framingham Offspring Study (2011) (1)
Risk Prediction for Individuals--Reply. (2015) (1)
Abstract 1469: Neck Circumference and Development of Cardiovascular Disease Risk Factors in the Framingham Heart Study (2009) (1)
Abstract 874: Education Independently Predicts Risk of Cardiovascular Disease but Only Modestly Improves Performance of Framingham Risk Functions (2009) (0)
Abstract P308: Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease (2016) (0)
Epidemiology and Prevention Arterial Stiffness and Cardiovascular Events The Framingham Heart Study (2010) (0)
Diet and Physical Activity Dietary Quality Predicts Adult Weight Gain : Findings from the Framingham Offspring Study (2006) (0)
Abstract 1152: Diet Quality, Lifestyle and Weight Change in Framingham Women and Men: The Framingham Nutrition Studies (2009) (0)
Abstract 17868: Longitudinal Trajectories of Clinical Risk Factors Are Associated With Incident Cardiovascular Disease in the Community (2016) (0)
Front & Back Matter (2012) (0)
Abstract P215: Common Beta-cell-associated Genetic Variants and Hypertension or Anti-hypertensive Drugs do not Interact in Their Positive Associations With Risk for Rising Fasting Glucose or Incident Type 2 Diabetes in Framingham (2012) (0)
Continuing Medical Education Program in Echocardiography (2009) (0)
Incremental value of rare genetic variants for the prediction of multifactorial diseases (2013) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Abstract 1037: Parental Occurrence of Intermittent Claudication is an Independent Risk Factor for Intermittent Claudication in Adult Offspring: The Framingham Heart Study (2009) (0)
Abstract 19425: Stress Perfusion Cardiac Magnetic Resonance Predicts Risk of Cardiac Events in Patients with Established Coronary Artery Disease (2012) (0)
Abstract 17169: Carotid Plaque Improves Discrimination and Reclassification of Cardiovascular Risk Prediction Models (2010) (0)
Observability and its impact on differential bias for clinical prediction models (2022) (0)
Impact of Clopidogrel Pretreatment on Ischemic Complications of PCI among Bivalirudin-Treated Patients: Results from the EVENT Registry (2010) (0)
editorial On the Quantitative Assessment of Predictive Biomarkers (2015) (0)
Abstract W P269: High vs. Moderate-intensity Statin Therapy After Ischemic Stroke: Findings from PROSPER (2015) (0)
Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction Heart Failure (2008) (0)
Abstract 13308: Prevalent Cardiovascular Disease and Progression of Carotid Intima-Media Thickness (2011) (0)
Algorithms for assessing cardiovascular risk in women. Authors' reply (2007) (0)
Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease (2017) (0)
Dietary Quality, Overweight, and Obesity in Women: The Framingham Nutrition Studies (2006) (0)
Prognostic Impact of Hybrid Comprehensive Telerehabilitation Regarding Diastolic Dysfunction in Patients with Heart Failure with Reduced Ejection Fraction—Subanalysis of the TELEREH-HF Randomized Clinical Trial (2022) (0)
LOW EJECTION FRACTION: COMMON LINK BETWEEN ARTERIAL AND VENOUS EVENTS IN PATIENTS UNDERGOING PCI (2013) (0)
Abstract P345: Prediction of Cardiovascular Disease Events and Death using Multiple Biomarkers in African Americans: the Jackson Heart Study (2014) (0)
The Duke Health Data Science Internship Program: Integrating the Educational Mission into Real-World Research (2018) (0)
Sharp increase in statin use and large changes in lipids and hsCRP in adults >=55 years of age in Poland during the last decade (2013) (0)
Abstract 12621: B-Type-Natriuretic Peptide and C-Reactive Protein in the Prediction of Atrial Fibrillation Risk: The CHARGE-AF Consortium (2012) (0)
Events) Registry Report From the EVENT (Evaluation of Drug Eluting Stents and Ischemic Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents: A In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention (2011) (0)
Scientiﬁc, societal, and economic consequences of releasing interim data from clinical trials (2016) (0)
Cross-Sectional Associations of Lipid Concentrations to Left Ventricular Structural Attributes (2010) (0)
Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk: the Framingham Offspring Study (2013) (0)
EXAMINATION OF HS-CRP ELEVATION IN PATIENTS WITH HISTORY OF MYOCARDIAL INFARCTION IN THE U.S. (2017) (0)
Heart failure patients' adherence to hybrid comprehensive telerehabilitation and its impact on prognosis based on data from TELEREH-HF randomized clinical trial (2020) (0)
Application of the new cholesterol guidelines. (2014) (0)
In adults without CV disease, most prediction scores overestimated risk for atherosclerotic CV events (2015) (0)
nique Dietary Patterns and Chronic Disease isk Profiles of Adult Men : The Framingham utrition Studies (2005) (0)
Developing a framework for a comprehensive data sharing program (2017) (0)
Abstract 13376: Lipid-Lowering Therapy Decreases Common Carotid Artery Intima-Media Thickness (IMT) Progression in Individuals Free of Prevalent Cardiovascular Disease: The Framingham Heart Study (2011) (0)
Abstract LB-327: Validation of a breast cancer risk prediction model in African American women (2012) (0)
P6365Contrasting the impact of the European (ESC/ESH 2018) versus American (ACC/AHA 2017) high blood pressure clinical practice guidelines in Poland (2019) (0)
Discriminative ability, reclassification and net benefit: Research methodology No. 7: The predictive value of biomarkers (2012) (0)
Abstract 9: Clinical Effectiveness of Statin Therapy after Ischemic Stroke: Primary Results from the PROSPER Study (2015) (0)
Abstract W MP106: Clinical Effectiveness of Anticoagulation with Warfarin among Ischemic Stroke Patients with Atrial Fibrillation: Findings from the Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2015) (0)
Abstract WMP85: Clinical Effectiveness of Direct Oral Anticoagulants (DOACs) vs. Warfarin in Older Ischemic Stroke Patients With Atrial Fibrillation: Findings From Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2019) (0)
Comparison of a Historical Food Frequency Questionnaire with a Three-Day Diet Record (2010) (0)
BIVALIRUDIN VS. UNFRACTIONATED HEPARIN IN PATIENTS UNDERGOING STENTING OF SAPHENOUS VEIN GRAFTS. AN ANALYSIS FROM THE EVENT REGISTRY (2010) (0)
Abstract 21062: Association Between High-Density Lipoprotein Cholesterol With All-Cause Death and Cardiovascular Events in a Primary Prevention Population (2017) (0)
Abstract 15840: Clinical Predictors of Heart Failure with Preserved vs Reduced Ejection Fraction: Data from the Framingham Heart Study (2010) (0)
Relationships between physical capacity and depression in heart failure patients undergoing hybrid comprehensive telerehabilitation vs usual care results of the TELEREH-HF randomized clinical trial (2021) (0)
Abstract 13665: Atrial Fibrillation Patterns in the Community and Risks of Stroke, Heart Failure, or Death (2011) (0)
PredictedLong-TermCardiovascularRiskAmong YoungAdultsintheNationalLongitudinalStudyof AdolescentHealth (2014) (0)
Abstract 17: Association Between Pre-stroke Depression and Patient Reported Outcomes After Acute Ischemic Stroke (2018) (0)
Abstract 20166: Development of a Risk Prediction Model for 1-Year Mortality After Surgical vs. Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis (2016) (0)
HEAD-TO-HEAD COMPARISON OF STATINS VERSUS FIBRATES IN REDUCING PLASMA FIBRINOGEN CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (0)
Abstract 3122: Differences in Intima Media Thickness of the Common and Internal Carotid Arteries (2008) (0)
Comparison of Two Nutritional Risk Scores to Assess Overweight and Obesity Risk in Women: The Framingham Nutrition Studies (2008) (0)
Have lower efficacy but similar effectiveness to inhaled corticosteroids (2016) (0)
Abstract 6201: Ankle-brachial Index And Fibrinogen Improve Cardiovascular Risk Prediction And Classification (2008) (0)
Abstract 1191: Trends in Cardiovascular Disease Risk Factors among Middle-Aged Individuals with and without Diabetes in the Framingham Heart Study (2008) (0)
Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs (2015) (0)
Understanding increments in model performance metrics (2012) (0)
Abstract 17105: Lifecourse Analysis Reveals Adverse Cardiovascular Disease Risk Factor Profiles up to 30 Years Prior to the Diagnosis of Diabetes (2010) (0)
Abstract 14203: Risk Factors for the Development of Carotid Artery Plaque: The Framingham Heart Study (2011) (0)
Abstract P117: Elevated Liver Transaminases are Associated with an Increased Risk of Atrial Fibrillation (2012) (0)
Thirty year risk of cardiovascular disease and key risk factors increase with increasing thyroid stimulating hormone in adolescents (2013) (0)
Abstract TMP39: Patterns of Discharge Antidepressant Therapy Use After Acute Ischemic Stroke: Insights From the Prosper Study (2018) (0)
Adherence to Adding ICS to Rescue Therapy in a Pragmatic Trial with Adults with Asthma– a Pilot Study (2018) (0)
CORONARY ARTERY CALCIUM SCORE VERSUS A MULTIPLE BIOMARKER APPROACH FOR CORONARY HEART DISEASE RISK ASSESSMENT: MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (2013) (0)
Abstract 13249: European and American Blood Cholesterol Guidelines Result in Similar Rates of Statin Recommendations when Applied to a Country with High Cardiovascular Disease Risk (2014) (0)
Cardiovascular Disease Risk Prediction in Young Adults-The Next Frontier. (2022) (0)
Abstract 17325: Association of Risk Adjusted 30 Day Heart Failure Readmission Rates Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes: Findings From the American Heart Association Get With the Guidelines-Heart Failure Program (2016) (0)
Implante valvular aórtico transcatéter frente a quirúrgico. Comparación con propensity score (2018) (0)
WHAT IS THE OPTIMAL RATE OF DRUG-ELUTING STENT USE? INSIGHTS FROM TEMPORAL ANALYSIS OF THE MULTICENTER EVENT REGISTRY (2010) (0)
SEASONAL, REGIONAL, AND CIRCADIAN VARIATIONS OF ACUTE MYOCARDIAL INFARCTION: FINDINGS FROM THE GET WITH THE GUIDELINES- CORONARY ARTERY DISEASE (GWTG-CAD) PROGRAM (2015) (0)
Obesity and Hypothyroidism : Symbiotic Coexistence. Authors' reply (2008) (0)
Obesity confers similar 30-year risk of cardiovascular disease or diabetes as hypertension or hypercholesterolemia in young adults (2013) (0)
Trajectories of Non-HDL C Across Midlife: Implications for Cardiovascular Prevention (2020) (0)
1 A Comparison of Overall Obesity and Abdominal Adiposity in Predicting the Risk of Mortality Among US Adults (2008) (0)
Abstract 3647: Dietary Patterns and Risk of Increased Carotid Intima-Media Thickness in Women: The Framingham Nutrition Studies (2007) (0)
Coronary Heart Disease Impact of Impaired Fasting Glucose on Cardiovascular Disease The Framingham Heart Study (2008) (0)
Obesity and Hypothyroidism: Symbiotic Coexistence--Reply (2008) (0)
Abstract 10621: Prediction of Incident Atherosclerotic Cardiovascular Disease Using Traditional and Polygenic Risk Score Modeling: The Million Veteran Program Experience (2021) (0)
Abstract 5993: One-Year Clinical Outcomes of Sirolimus-Eluting vs. Paclitaxel-Eluting Stents in Unselected Patients: Results from the Multicenter EVENT Registry (2008) (0)
Informatics-Enabled Learning Health Systems: Strategies for Success from Four Academic Medical Centers (2019) (0)
Abstract 5828: Carotid Artery Plaque is More Strongly Associated With Prior Cardiovascular Risk Factor Levels Than With Current Risk Factor Levels (2009) (0)
Abstract 10: Pre-stroke Antithrombotic Therapy and Stroke Severity in Acute Ischemic Stroke Patients with Atrial Fibrillation (2016) (0)
Plasma Homocysteine and Carotid Artery Intima‐Media Thickness: Site‐Specific Associations in the Framingham Offspring Cohort (2006) (0)
81Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis (2017) (0)
Sex Specific Differences in the Predictive Value of Cholesterol Homeostasis Markers and 10‐Year CVD Event Rate in Framingham Offspring Study (2013) (0)
Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart Disease. (2022) (0)
Letter by Sniderman et al Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease". (2019) (0)
Association of obesity and levels of Inflammatory markers on treatment outcome with adjunctive L-methylfolate (Deplin) in major depressive disorder patients who are inadequate responders to selective serotonin reuptake Inhibitors (2015) (0)
Diet Quality and Development of Abdominal Obesity in Women: Comparison of Two Composite Nutritional Risk Scores. The Framingham Nutrition Studies (2008) (0)
Practice of Epidemiology Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record (2016) (0)
Repeat BoneMineral Density Screening and Prediction of Hip andMajor Osteoporotic Fracture (2013) (0)
Vitamin D Deficiency and Risk of Cardiovascular Disease Epidemiology (2008) (0)
Understanding Algorithmic Bias in Clinical Prediction Models (2021) (0)
Abstract 14057: P Wave Indices and Risk of Atrial Fibrillation: Cross-Cohort Assessments From the Framingham Heart Study and Atherosclerosis Risk in Communities Study (2013) (0)
Abstract P297: Long-Term Benefit Comparison of Absolute Risk Reduction versus Absolute Risk to Prioritize Statin Therapy (2018) (0)
Practice of Epidemiology Interpreting Incremental Value of Markers Added to Risk Prediction Models (2012) (0)
Abstract P237: The Society of Thoracic Surgeons Risk Score Is Superior to the EuroSCORE in Discriminating Long-Term Mortality in Patients Undergoing Nonemergent Unprotected Left Main Stenting (2011) (0)
Guideline Recommendations for Statin Therapy-Reply. (2017) (0)
Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium (2015) (0)
Abstract # 12286: Contribution of Family History to the Prediction of Atrial Fibrillation Risk (2010) (0)
P3822Risk prediction for ASCVD in primary prevention patients on statin therapy (2019) (0)
Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program. (2023) (0)
Needles in a Haystack: Finding Qualitative and Quantitative Collaborators in Academic Medical Centers. (2023) (0)
PREVALENCE AND MANAGEMENT OF PATIENT-REPORTED SYMPTOMS ON STATIN THERAPY: INSIGHTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY (2016) (0)
ONE SIZE DOES NOT FIT ALL: CONSIDERING DIFFERENT STATIN THERAPY CUTPOINTS BY AGE AND SEX (2015) (0)
Abstract 14701: Future Risk of Cardiovascular Disease in Adults with Prolonged Exposure to High Blood Pressure (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael J Pencina?

Michael J Pencina is affiliated with the following schools:

Michael J Pencina's Academic­Influence.com Rankings

Michael J Pencina's Degrees

Why Is Michael J Pencina Influential?

Michael J Pencina's Published Works

Published Works

What Schools Are Affiliated With Michael J Pencina?

Michael J Pencina's AcademicInfluence.com Rankings